First-in-Human Single Ascending and Multiple Dose of GLPG0555
Clinical trial NCT01023321 · COMPLETED
Trial details
- NCT number
- NCT01023321
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.